ASX:RMD

ResMed Inc. · ASX · Healthcare · AUD · FY for 2025

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aAUD

Market data

24.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed
- Computed from the filing for 2025
25.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
27.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
32.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.14Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed

Price is the furthest below its sector's middle: 0.27 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

122

2023-06-30 to 2025-06-30100 at the start122

Sales: 100.00 on 2023-06-30 to 121.86 on 2025-06-30, up 22%.

Profit

156

2023-06-30 to 2025-06-30100 at the start156

Profit: 100.00 on 2023-06-30 to 156.06 on 2025-06-30, up 56%.

Shares in issue

99.9

2023-06-30 to 2025-06-30100 at the start99.9

Shares in issue: 100.00 on 2023-06-30 to 99.92 on 2025-06-30, down 0%.

Sales is at 122, Profit is at 156, Shares in issue is at 100, against 100 in 2023.

Sales is at 122, Profit is at 156, Shares in issue is at 100, against 100 in 2023.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100122
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Profit, where the first year is 100156
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Shares in issue, where the first year is 100100
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD